News
Seeing critical anatomy clearly during surgery can make all the difference. A fluorescence imaging technology developed by NIH inventors is moving closer to clinical testing through an exclusive patent license with Optosurgical, LLC. The license gives the Maryland-based surgical imaging company U.S
Imagine treating a genetic disease not by managing symptoms for life, but by correcting the underlying genetic error itself. Inventors at NIH are advancing that vision with a gene editing technology designed to deliver highly precise genetic corrections, opening new possibilities for therapies that
A promising new cancer technology from NIH could help improve how liver cancer is diagnosed and treated. Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the deadliest cancers worldwide, and better treatment options are urgently needed. NIH inventors have developed two fully
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2026 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are